We are live on ! Find out more
CTA

Chesley Taft & Associates Portfolio holdings

AUM $2.57B
1-Year Est. Return 22.93%
This Fund
S&P 500
This Quarter Est. Return
+6.48%
1 Year Est. Return
+22.93%
3 Year Est. Return
+80.85%
5 Year Est. Return
+97.37%
10 Year Est. Return
+353.09%
AUM
$917M
AUM Growth
+$54.3M
Cap. Flow
+$6.06M
Cap. Flow %
0.66%
Top 10 Hldgs %
20.19%
Holding
278
New
14
Increased
107
Reduced
83
Closed
13

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$7.47M
2
SYY icon
Sysco
SYY
+$4.91M
3
XOM icon
ExxonMobil
XOM
+$3.76M
4
IBM icon
IBM
IBM
+$3.1M
5
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
+$2.81M

Sector Composition

Rank Sector Weight
1 Healthcare 15.98%
2 Industrials 15%
3 Technology 11.71%
4 Consumer Staples 10.36%
5 Energy 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSS icon
51
Kohl's
KSS
$2.21B
$5.87M 0.64%
113,468
-500
-0.4% -$26.1K
SRCL
52
DELISTED
Stericycle Inc
SRCL
$5.77M 0.63%
50,035
-1,065
-2% -$123K
WFC icon
53
Wells Fargo
WFC
$258B
$5.71M 0.62%
138,186
+7,106
+5% +$303K
JPM icon
54
JPMorgan Chase
JPM
$933B
$5.64M 0.61%
109,102
+74
+0.1% +$3.97K
AMJ
55
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$5.63M 0.61%
126,317
+600
+0.5% +$27.6K
SLB icon
56
SLB Ltd
SLB
$72.6B
$5.63M 0.61%
63,748
-195
-0.3% -$16K
TMO icon
57
Thermo Fisher Scientific
TMO
$214B
$5.63M 0.61%
61,065
+75
+0.1% +$6.78K
GWW icon
58
W.W. Grainger
GWW
$64B
$5.43M 0.59%
20,755
+83
+0.4% +$21.6K
ADT
59
DELISTED
ADT Corp
ADT
$5.41M 0.59%
133,123
+82,634
+164% +$3.4M
TW
60
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$5.39M 0.59%
50,395
+650
+1% +$57.2K
NVS icon
61
Novartis
NVS
$301B
$5.3M 0.58%
77,042
-156
-0.2% -$10.3K
OXY icon
62
Occidental Petroleum
OXY
$55.6B
$5.24M 0.57%
58,483
+18,997
+48% +$1.63M
K
63
DELISTED
Kellanova
K
$5.24M 0.57%
94,982
-932
-1% -$55.6K
MDY icon
64
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$5.2M 0.57%
22,965
-163
-0.7% -$36.2K
ICE icon
65
Intercontinental Exchange
ICE
$87.7B
$5.07M 0.55%
139,765
+1,830
+1% +$66.3K
EEM icon
66
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$5.04M 0.55%
123,778
+1,649
+1% +$65.3K
IGSB icon
67
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$4.86M 0.53%
92,402
+4,174
+5% +$219K
APH icon
68
Amphenol
APH
$197B
$4.77M 0.52%
493,592
-5,760
-1% -$56.2K
HAL icon
69
Halliburton
HAL
$26.4B
$4.75M 0.52%
98,575
+76,775
+352% +$3.6M
J icon
70
Jacobs Solutions
J
$15.7B
$4.69M 0.51%
97,437
-296
-0.3% -$14.4K
ABBV icon
71
AbbVie
ABBV
$455B
$4.28M 0.47%
95,720
+233
+0.2% +$10.3K
PX
72
DELISTED
Praxair Inc
PX
$4.24M 0.46%
35,293
+415
+1% +$49.3K
REGN icon
73
Regeneron Pharmaceuticals
REGN
$76B
$4.24M 0.46%
13,556
-9,612
-41% -$2.53M
MRK icon
74
Merck
MRK
$321B
$4.04M 0.44%
88,886
+3,518
+4% +$161K
NTRS icon
75
Northern Trust
NTRS
$22.4B
$3.99M 0.43%
73,348
-4,442
-6% -$255K

Similar funds

Chesley Taft & Associates's Q3 2013 Portfolio in Review

As of Q3 2013, Chesley Taft & Associates held 278 positions worth $917M, up 6.3% from $863M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Chesley Taft & Associates's Q3 2013 filing shows 14 new, 107 increased, 83 reduced and 13 closed positions. Its largest new stake was Cencora: 36,285 shares worth $2.22M. The largest sale was Oracle, an estimated $7.47M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Industrials and Technology.

  • Chesley Taft & Associates's largest Q3 2013 buy was Cencora: 36,285 shares worth $2.22M.
  • Chesley Taft & Associates added most to Du Pont De Nemours E I in Q3 2013, an estimated $9.06M increase.
  • Chesley Taft & Associates's biggest Q3 2013 reduction was Oracle, cutting an estimated $7.47M.
  • Chesley Taft & Associates fully exited TYCO INTL PLC COM SHS (IRL) in Q3 2013, selling an estimated $2.81M.
  • Chesley Taft & Associates's ten largest holdings make up 20% of its $917M portfolio in Q3 2013.
  • Chesley Taft & Associates opened 14 new positions and closed 13 in Q3 2013.
  • Chesley Taft & Associates's portfolio value rose 6.3% quarter-over-quarter to $917M.

Based on Chesley Taft & Associates's 13F filing for Q3 2013, filed 25 Oct 2013.